Effect of Intralymphatic Immunotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

February 1, 2017

Conditions
AllergyImmune ToleranceInjection Site Discomfort
Interventions
DRUG

Alk (225) Phleum Pratense. 0.1 ml of 10,000 standard quantity units/ml.

4

DRUG

alk (225) Phleum Pratense. 0.1 ml of 10,000 standard quantity units/ml.

3 injection into a lymphnode

DRUG

0.1 ml Isoton saline

4 injection into a lymphnode

Trial Locations (1)

8000

Lungemedicinsk Forskningsafdeling. Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02255604 - Effect of Intralymphatic Immunotherapy | Biotech Hunter | Biotech Hunter